ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
ResMed (NYSE: RMD, ASX: RMD) has announced plans to release its financial and operational results for the first quarter of fiscal year 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ResMed (NYSE: RMD, ASX: RMD) has announced plans to release its financial and operational results for the first quarter of fiscal year 2025. The release is scheduled for Thursday, October 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. This announcement provides investors and analysts with a specific date to anticipate the company's quarterly performance update, which is important for assessing ResMed's financial health and market position in the medical equipment industry.
Details
News Market Reaction – RMD
The recorded move for RMD in the trading session of this news was -1.87%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
| http://investor.resmed.com |
| Thursday, October 24, 2024 |
| 1:30 p.m. PDT / 4:30 p.m. EDT |
| London, Thursday, October 24, 2024, 9:30 p.m. BST Sydney, Friday, October 25, 2024, 7:30 a.m. AEDT |
Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from October 24, 2024, until November 7, 2024, at:
- U.S.: +1 877.660.6853
- International: +1 201.612.7415
- Conference ID: 13749420
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| +1 858.836.5000 | +1 619.510.1281 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.